FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003150008> ?p ?o ?g. }

• W2003150008 endingPage "476" @default.
• W2003150008 startingPage "467" @default.
• W2003150008 abstract "The value of the T3 suppressed 20-min uptake test for the prediction of post-treatment outcome was studied in 193 unselected patients with GRAVES' disease treated with thionamide drugs and T3. One hundred and twenty-nine of 193 patients were studied previously and followed thereafter (Group A). Sixty-four were newly treated patients: thirty-three (Group B) were treated at the same hospital as Group A; thirty-one (Group C) were treated at another hospital. In total, 126 patients out of 193 satisfied our criteria for suppression (total suppression rate, 65%). The suppression rate for new patients (55% in Group B, 52% in Group C) was similar to that for Group A in 1977 (49%) after comparable duration of treatment. The suppression rate for Group A increased with prolongation of the treatment period (49% in 1977 and 71% in 1981). As to the time course of suppression, it was observed that about two-thirds of the suppressed patients satisfied the criteria for suppression within 3 years of starting treatment. The number of suppressed patients per year decreased thereafter as the treatment periods increased. However, the yearly suppression rate did not decrease with time. The time course of suppression in each patient could not be predicted from the results of initial thyroid function tests. The overall remission rate among the 120 suppressed patients followed for 1–13 (mean, 4) years was 96%, which was almost equal to the value obtained in Group A in 1977 (95%) with the average follow-up period of 2 years. Among the 46 patients in Group A followed for 5–13 (mean, 7) years, no increase in relapse was observed with prolonged follow-up periods. Examination on the relationship between the duration of treatment and the post-treatment outcome" @default.
• W2003150008 created "2016-06-24" @default.
• W2003150008 creator A5020551711 @default.
• W2003150008 creator A5044061030 @default.
• W2003150008 creator A5049360242 @default.
• W2003150008 creator A5065213823 @default.
• W2003150008 creator A5072232523 @default.
• W2003150008 creator A5075784288 @default.
• W2003150008 creator A5088311218 @default.
• W2003150008 date "1983-10-01" @default.
• W2003150008 modified "2023-10-01" @default.
• W2003150008 title "OUTCOME OF PATIENTS WITH GRAVES' DISEASE AFTER LONG-TERM MEDICAL TREATMENT GUIDED BY TRIIODOTHYRONINE (T3) SUPPRESSION TEST" @default.
• W2003150008 cites W1965517604 @default.
• W2003150008 cites W1967550328 @default.
• W2003150008 cites W1972181389 @default.
• W2003150008 cites W1978404529 @default.
• W2003150008 cites W1995686528 @default.
• W2003150008 cites W1999958677 @default.
• W2003150008 cites W2000047850 @default.
• W2003150008 cites W2003223603 @default.
• W2003150008 cites W2034827046 @default.
• W2003150008 cites W2041270716 @default.
• W2003150008 cites W2042515565 @default.
• W2003150008 cites W2059852480 @default.
• W2003150008 cites W2060617491 @default.
• W2003150008 cites W2064363090 @default.
• W2003150008 cites W2071782794 @default.
• W2003150008 cites W2157047803 @default.
• W2003150008 cites W2169144757 @default.
• W2003150008 cites W2337157164 @default.
• W2003150008 doi "https://doi.org/10.1111/j.1365-2265.1983.tb00021.x" @default.
• W2003150008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6688767" @default.
• W2003150008 hasPublicationYear "1983" @default.
• W2003150008 type Work @default.
• W2003150008 sameAs 2003150008 @default.
• W2003150008 citedByCount "18" @default.
• W2003150008 crossrefType "journal-article" @default.
• W2003150008 hasAuthorship W2003150008A5020551711 @default.
• W2003150008 hasAuthorship W2003150008A5044061030 @default.
• W2003150008 hasAuthorship W2003150008A5049360242 @default.
• W2003150008 hasAuthorship W2003150008A5065213823 @default.
• W2003150008 hasAuthorship W2003150008A5072232523 @default.
• W2003150008 hasAuthorship W2003150008A5075784288 @default.
• W2003150008 hasAuthorship W2003150008A5088311218 @default.
• W2003150008 hasConcept C126322002 @default.
• W2003150008 hasConcept C134018914 @default.
• W2003150008 hasConcept C2776652619 @default.
• W2003150008 hasConcept C2777785397 @default.
• W2003150008 hasConcept C2778288131 @default.
• W2003150008 hasConcept C2779134260 @default.
• W2003150008 hasConcept C526584372 @default.
• W2003150008 hasConcept C71924100 @default.
• W2003150008 hasConcept C90924648 @default.
• W2003150008 hasConceptScore W2003150008C126322002 @default.
• W2003150008 hasConceptScore W2003150008C134018914 @default.
• W2003150008 hasConceptScore W2003150008C2776652619 @default.
• W2003150008 hasConceptScore W2003150008C2777785397 @default.
• W2003150008 hasConceptScore W2003150008C2778288131 @default.
• W2003150008 hasConceptScore W2003150008C2779134260 @default.
• W2003150008 hasConceptScore W2003150008C526584372 @default.
• W2003150008 hasConceptScore W2003150008C71924100 @default.
• W2003150008 hasConceptScore W2003150008C90924648 @default.
• W2003150008 hasIssue "4" @default.
• W2003150008 hasLocation W20031500081 @default.
• W2003150008 hasLocation W20031500082 @default.
• W2003150008 hasOpenAccess W2003150008 @default.
• W2003150008 hasPrimaryLocation W20031500081 @default.
• W2003150008 hasRelatedWork W1981780460 @default.
• W2003150008 hasRelatedWork W2066485846 @default.
• W2003150008 hasRelatedWork W2070295037 @default.
• W2003150008 hasRelatedWork W2080164112 @default.
• W2003150008 hasRelatedWork W2092628191 @default.
• W2003150008 hasRelatedWork W2108687096 @default.
• W2003150008 hasRelatedWork W2123776185 @default.
• W2003150008 hasRelatedWork W2152205888 @default.
• W2003150008 hasRelatedWork W2156615339 @default.
• W2003150008 hasRelatedWork W2413042786 @default.
• W2003150008 hasVolume "19" @default.
• W2003150008 isParatext "false" @default.
• W2003150008 isRetracted "false" @default.
• W2003150008 magId "2003150008" @default.
• W2003150008 workType "article" @default.